Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

What To Expect From AMD's 2nd Annual 'Capsaicin & Cream' Live Event

Share:
What To Expect From AMD's 2nd Annual 'Capsaicin & Cream' Live Event

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) gained more than 7 percent on Monday and ticked higher by another 1 percent early Tuesday morning ahead of the company's second Annual Capsaicin & Cream live event.

Here's what to expect from the event.

Event Expectations

According to Wccftech, AMD's presentation is quite "sizable" and could follow last year's presentation when the company teased the community with a new product. Last year the company offered a glimpse of its yet unreleased Polaris graphics architecture and on Tuesday AMD could offer a glimpse of Vega.

Related Link: The Hype Surrounding Advanced Micro Device's Ryzen Product Launch

What's Vega?

Wccftech noted that Vega is AMD's newest 14nm graphics architecture and represents the most notable leap forward for the company in years. In fact, demos that AMD already showcased of Vega have "painted a picture of an enthusiast class chip."

In addition, AMD's engineers have scheduled at least one other session that is known to detail its equally hotly anticipated Ryzen CPUs, which reportedly are scheduled to begin shipping as early as March 2.

Investor expectation heading into Tuesday's presentation is high and some Wall Street analysts are saying that AMD has zero room for any error in 2017 as the stock is now priced to "perfection."

Posted-In: AMD Ryzen AMD Vega Capsaicin & CreamNews Events Movers Tech Media Best of Benzinga

 

Related Articles (AMD)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Analyst Says Teva Is 'Plagued With Problems,' Downgrades On Challenging Outlook

Valeant's Guidance Looks Conservative